A polymorphism in the mouse neuronal α4 nicotinic receptor subunit results in an alteration in receptor function

被引:38
作者
Dobelis, P
Marks, MJ
Whiteaker, P
Balogh, SA
Collins, AC
Stitzel, JA
机构
[1] Univ Michigan, Med Ctr, Dept Pharmacol, Ann Arbor, MI 48109 USA
[2] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Boulder, CO 80309 USA
关键词
D O I
10.1124/mol.62.2.334
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nicotine-stimulated Rb-86(+) efflux and [H-3] cytisine binding, both of which seem to measure the nicotinic acetylcholine receptor, composed of alpha4 and beta2 subunits, were assessed in eight brain regions obtained from 14 inbred mouse strains. The potential role of a single nucleotide polymorphism (SNP) in the nicotinic receptor alpha4 subunit gene (Chrna4) on nicotinic receptor binding and function in mice was also evaluated. This SNP leads to an alanine-to-threonine variation at amino acid position 529 of the nascent alpha4 subunit polypeptide. Both nicotine-stimulated Rb-86(+) efflux and [H-3] cytisine binding were found to vary across brain regions and among mouse strains. Variability in nicotine-stimulated Rb-86(+) efflux was positively correlated (r > 0.9) within each strain with the number of [H-3] cytisine binding sites. However, the number of [H-3] cytisine binding sites was not correlated with nicotine-stimulated Rb-86(+) efflux across mouse strains. In contrast, the Chrna4 polymorphism was associated with receptor function across mouse strains: Rb-86(+) efflux was greater in seven of the eight brain regions studied in those mouse strains that carry the Ala-529 variant of Chrna4. The Chrna4 SNP did not seem to influence the number of [H-3] cytisine binding sites across mouse strains. These data indicate that inbred mouse strains exhibit differences in receptor function that cannot be attributed to variation in receptor expression but may be explained, at least in part, by the missense polymorphism in the alpha4 subunit.
引用
收藏
页码:334 / 342
页数:9
相关论文
共 39 条
[1]  
Buisson B, 1996, J NEUROSCI, V16, P7880
[2]  
Corringer PJ, 1998, J NEUROSCI, V18, P648
[3]   DECREASED SENSITIVITY TO NICOTINE-INDUCED SEIZURES AS A CONSEQUENCE OF NICOTINE PRETREATMENT IN LONG-SLEEP AND SHORT-SLEEP MICE [J].
DEFIEBRE, CM ;
COLLINS, AC .
ALCOHOL, 1988, 5 (01) :55-61
[4]   ACTIVATORS OF PROTEIN-KINASE-C ENHANCE ACETYLCHOLINE-RECEPTOR DESENSITIZATION IN SYMPATHETIC-GANGLION NEURONS [J].
DOWNING, JEG ;
ROLE, LW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7739-7743
[5]  
Fenster CP, 1999, MOL PHARMACOL, V55, P432
[6]   REGIONS OF BETA-4.BETA-2 SUBUNIT CHIMERAS THAT CONTRIBUTE TO THE AGONIST SELECTIVITY OF NEURONAL NICOTINIC RECEPTORS [J].
FIGL, A ;
COHEN, BN ;
QUICK, MW ;
DAVIDSON, N ;
LESTER, HA .
FEBS LETTERS, 1992, 308 (03) :245-248
[7]   Pharmacogenetic variability in neuronal nicotinic receptor-mediated antinociception [J].
Flores, CM ;
Wilson, SG ;
Mogil, JS .
PHARMACOGENETICS, 1999, 9 (05) :619-625
[8]  
FLORES CM, 1992, MOL PHARMACOL, V41, P31
[9]   NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS EXPRESSED IN XENOPUS OOCYTES - ROLE OF THE ALPHA SUBUNIT IN AGONIST SENSITIVITY AND DESENSITIZATION [J].
GROSS, A ;
BALLIVET, M ;
RUNGGER, D ;
BERTRAND, D .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1991, 419 (05) :545-551
[10]  
GURANTZ D, 1993, MOL PHARMACOL, V43, P807